OPT
Pharmaceuticals, Biotechnology & Life Sciences
Opthea
- Short interest
- 0.01%
- −0.47 pp 30d
- as of 13 July 2026
- Reported shorts
- 70.6K
- Shares on issue
- 1.368B
Opthea (OPT) financials
Results, ratios and statements
Fundamentals
Our data providers hold no financial statements for OPT (last checked 14 Oct 2026). The company's own filings are listed below.
Financial reports
The company's own filings, newest first
- Appendix 4E and 2026 Annual ReportAnnual Results31 Aug 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report27 Jul 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report30 Apr 2026via asx_announcements
- Appendix 4D and Half Year Report for period 31 Dec 2025Half Year Results2 Mar 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report30 Jan 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report31 Oct 2025via asx_announcements
- Annual Report to shareholdersAnnual Report15 Sep 2025via asx_announcements
- Preliminary Final ReportAnnual Results29 Aug 2025via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report30 Jul 2025via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report30 Apr 2025via asx_announcements
Showing 10 of 65 reports